You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CRSP Exercise Disclosure
Patel Naimish · SEC Form 4 · Filed Jun 1, 2026
Exercise
Reported value range
Not reported
Patel Naimish Chief Medical Officer
CRSP
Transaction date
May 28, 2026
Public filing date
Jun 1, 2026
Filing lag
Filed 4 days later
CRSP daily price context
Close on/before transaction
$56.38
May 28, 2026
First close after public filing
$52.02
Jun 2, 2026
30-day return after filing
+6.92%
Through Jul 1, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Shares
- Quantity / price
- 10,000 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-251817
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$210.58K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Crispr Therapeutics Ag CRSP | Sale | May 29, 2026 | $210.58K |
| Crispr Therapeutics Ag CRSP | Exercise | May 28, 2026 | Not reported |
| Crispr Therapeutics Ag CRSP Current | Exercise | May 28, 2026 | Not reported |